Clinical Trials in Sweden

by Egle Pavyde | Mar 16, 2026 | Clinical Trials by Country

Clinical Trials in Sweden: Registry-Linked Research and World-Class Academic Sites Sweden is one of Europe’s most scientifically distinguished clinical trial environments. With a population of approximately 10.5 million, world-class academic hospitals, and an...

Clinical Trials in Austria

by Egle Pavyde | Mar 15, 2026 | Clinical Trials by Country

Clinical Trials in Austria: Academic Excellence and Central European Access Austria is a mid-sized European clinical trial country with a population of approximately 9.1 million and an academic medical infrastructure anchored by three medical universities – in Vienna,...

Clinical Trials in Poland

by Egle Pavyde | Mar 14, 2026 | Clinical Trials by Country

Clinical Trials in Poland: Large Patient Pool, Competitive Costs, and the Need for Rigorous Site Selection Poland is the largest country in this group, with a population of approximately 37.6 million – more than four times that of Belgium or Denmark. That scale,...

Interview with Oscar Salamanca, CEO of APICES

by Egle Pavyde | Feb 6, 2026 | News

On integration, change leadership, and strengthening Apices as one unified organization  In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...

Western vs Eastern Europe for Clinical Trials: How CTIS Is Reshaping Country Selection

by Egle Pavyde | Feb 2, 2026 | Clinical Trials by Country, News

Eastern vs Western Europe for Clinical Trials By Egle Pavyde, PhD, VP Business Development Europe is not one clinical-trial “country”. It is a portfolio of ecosystems operating under a shared legal framework, with meaningful differences in speed, feasibility, patient...